FINWIRES · TerminalLIVE
FINWIRES

Gan & Lee Pharmaceuticals Gets Nod to Market Dazparda in Europe

作者

-- The European Commission granted Gan & Lee Pharmaceuticals (SHA:603087) marketing authorization for insulin aspart injection Dazparda, according to a Shanghai bourse filing on Thursday.

The Chinese pharmaceutical company's unit, Gan & Lee Pharmaceuticals Europe, is the authorized marketer of the product in Europe.

The company's shares rose 1% at the close.

相关文章